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Tolerance to Skin and Vascularized Cardiac Allografts Using 
Mixed Chimerism 
P.M. Markus, G. Selvaggi, X. Cai, T.E. Starzl, and H.D. Roher 
I N recent years a number of methods have been devel-
oped to induce donor-specific transplantation tolerance 
in adult recipients using bone marrow transplantation. 1-4 
One approach. using a mixture of syngeneic and allogeneic 
bone marrow to prepare allogeneic chimeras (A + B - A) 
has been demonstrated to be effective in achieving long-
term donor-specific transplantation tolerance to alloanti-
gens in mice. 5 We adapted the model of mixed chimerism 
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Fig 1. Life table survival of ACI skin (A) or cardiac (B) grafts in 
naive, syngeneic, reconstiMed, and mixed chimeras. Four weeks 
after bone marrow transplantation, each animal received an ACI, 
LEW, and BN skin, or an ACI cardiac graft (only donor type ACI 
grafts are presented). Animals that received mixed bone marrow 
yet repopulated syngeneically were analyzed separately (MIXED 
BMTX, syngeneic repopulation). Each group consisted of six to 10 
animals. 
to the rat to investigate the response of mixed allogeneic 
chimeras to skin and primarily vascularized organ grafts 
that are limited in mice due to technical difficulties. 
MATERIALS AND METHODS 
Bone Marrow Transplantation 
LEW recipient rats (225 to 250 g) were lethally irradiated with 
1000 rad total body irradiation and reconstituted with a mixture of 
syngeneic LEW (7 x 106 cells/recipients) and allogeneic ACI (43 
x 106 cells/recipient) T cell-depleted bone marrow (LEW + 
ACI-LEW1. T-cell depletion (TCD) was performed using mag-
netic polymer beads (Dynabeads M4501. Bioproducts for Science. 
IndianapolIs. lndl coated with monoclonal antibody (MAbl OX-19 
(anti-CDS). Flow cytometnc analyses of spleen controls were 
routinely pertormed to assess successful depletion of OX-19+ T 
cells. Syngeneic reconstituted controls received 50 x 100 TCD 
syngeneic bone marrow cells (LEW-LEW). 
Assessment of Chimerism 
Four weeks after reconstitution with mixed allogeneic bone mar-
row. animals were assessed for the presence of allogeneic donor 
type ACI T cells. Strain-specific MAb for the RTI.A major 
histocompatibility complex (MHO class I antigen was used as 
primary biotinylated antibody. 
Organ Grafting 
Full thickness skin grafts of donor (ACl). third party (BN). and 
host type (LEW) were performed using a modified method of 
Billingham.6 A heterotopic abdominal heart transplant model was 
used for vascularized grafts. 
RESULTS 
Survival of Mixed Allogeneic Reconstituted Rats 
Recipient survival after transplantation of the mixed bone 
marrow inoculum was 96% at 150 days. Thirty seven 
percent of all animals (19 of 52) repopulated as mixed 
chimeras with detectable ACI donor type peripheral blood 
lymphocytes. The remainder repopulated syngeneically, 
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despite the mixed ACI + LEW bone marrow transplants. 
Subsequently, the animals that repopulated as mixed chi-
meras were used for further investigation (I) to assess the 
. percentage of chimerism and (2) for transplantation exper-
iments with skin and cardiac iso- and allografts. 
Animals that repopulated as mixed chimeras were evalu-
ated at I, 3. and 5 months after reconstitution for the 
percentage of chimerism. The percentage of donor type 
allogeneic ACI cells varied from 0.5 to 82% and this was 
maintained throughout the study. 
Survival of Skin and Cardiac Grafts in Mixed Allogeneic 
Reconstituted Rats 
Although syngeneic repopulated animals rejected donor 
(AC!) and third-party (BN) skin grafts. all chimeric ani-
mals accepted host (LEW) (data not shown) and donor 
type (AC!) (Fig la and b) skin and cardiac grafts. but 
rt:Jected third-party (BN) grafts at the same time as naive 
controls (data not shown). The level of chimerism did not 
influence the survival of skin or cardiac grafts. All donor 
type skin and cardiac grafts survived more than 150 days 
without histologic evidence of chronic rejection. Animals 
that repopulated syngeneically without detectable chimer-
ism uniformly rejected ACI and BN skin and cardiac 
grafts. 
DISCUSSION 
We report a model that achieves stable mixed allogeneic 
chimerism using transplantation of a mixture of TCD 
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allogeneic and TCD syngeneic bone marrow. Transplanta-
tion tolerance was specific for skin and also vascularized 
cardiac grafts across an MHC and non-MHC barrier 
(ACI-LEW). The model is still limited by a high number of 
rats rejecting the allogeneic bone marrow inoculum and 
repopulating syngeneically. Neither increasing the total 
number of allogeneic cells nor increasing the number of 
totally transplanted cells up to 200 x 10° cells/recipient 
(data not shown) promoted the acceptance of donor type 
ACI marrow. It is well recognized that TCD of the 
syngeneic component of the mixed bone marrow inoculum 
is critical in order to allow engraftment of the allogeneic 
bone marrow cells when mixed allogeneic reconstitution is 
performed.7 One could argue that TCD using OX-I9-
coated magnetic beads is inefficient in removing all synge-
neic CD-5+ T cells. which then prevents engraftment of 
the ACI bone marrow component. It is also possible that 
the rat exhibits a greater level of alloresistance to engraft-
ment that we have found in mouse-to-rat and rat-to-mouse 
transplantation experiments (data not shown). 
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